Vapejoose, Inc.

Warning LetterOpen

Stephen Knight Vapejoose, Inc. 1021 28th St. SW Wyoming , MI 49509 United States steve@vapejoose.com support@vapejoose.comIssued May 20, 2022Center for Tobacco Products

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations1

Issue DateMay 20, 2022

Product TypeTobacco

StatusOpen

Letter Details

Firm: Vapejoose, Inc.
Location: Stephen Knight Vapejoose, Inc. 1021 28th St. SW Wyoming , MI 49509 United States steve@vapejoose.com support@vapejoose.com
FEI Number: N/A
Country: United States
Issue Date: May 20, 2022
Issuing Office: Center for Tobacco Products
Product Type: Tobacco
Status: Open

Summary

Vapejoose, Inc. was cited for manufacturing and distributing e-liquid tobacco products without the required premarket authorization order mandated by the Family Smoking Prevention and Tobacco Control Act. The FDA determined that the company's e-liquid products sold through shopjoose.com qualified as newly deemed tobacco products subject to FDA jurisdiction as of August 8, 2016, and therefore required marketing authorization under section 910 of the Federal Food, Drug, and Cosmetic Act prior to sale. The inspection of the company's website revealed the products were being offered for sale in the United States without obtaining the necessary premarket approval from FDA.

Vapejoose, Inc. FDA Warning Letter, May 20, 2022